by Jose Leal, 5th December 2025 Where should we build the next stage of our work? This question has been driving my thinking about the Gulf for the past year. As Ophiomics moves from clinical validation…
Why Qatar can – and must – claim the diagnostics translation space before regional competitors occupy it By José Pereira Leal, PhD Published on Linkedin on Dec 4th, 2025. Over the past year, I’ve been…
Published on LinkedIn on Dec 1st, 2025 In the global race for medical innovation, market size matters, but market access matters more. Today, a medical device manufacturer targeting the Gulf Cooperation Council (GCC) faces a…
Published on Linkedin on Nov 23rd I visited Wuhan once, in 2004, teaching for a couple of weeks as part of EMBO’s World Program. I can’t claim the trip left me with profound insights about…
Published on LinkedIn on Nov 20th In Part 1/2 (https://www.linkedin.com/pulse/rebuilding-case-diagnostics-investment-12-reflections-pereira-leal-swvbf), I discussed why diagnostics face a systematic funding gap despite being essential infrastructure for precision medicine, and outlined five strategic directions for entrepreneurs building diagnostic…
Published on LinkedIn on Nov 17th The diagnostics sector faces a paradox: we’re living through a precision medicine revolution, yet the tools that make precision medicine possible remain chronically underfunded. In 2023-2024, diagnostics captured just…
Published on linkedin A few days after Web Summit Lisbon 2025, one impression remains very clear to me: how differently national hashtag#innovationecosystems choose to present themselves. As someone working at the intersection of precision diagnostics and…
Published on Linkedin on November 8th, 2025 Reading Qatar’s latest precision medicine and national strategy reports as my flight approached Doha, I found myself genuinely impressed and, as a veteran of biomedical strategy, more than…
Published on Linkedin on October 12, 2025 I just spent three intense days at BioSpain 2025 (https://www.asebio.com/en/news-events/news/biospain-2025-closes-record-attendance-and-passes-baton-bilbao-2026-host-city), participating in a most intense (!) partnering marathon, and also had the privilege of participating in two roundtables.…
At 35, Sarah suffered a heart attack that a €30 genetic test could have prevented. Her story isn’t unusual, it’s a mirror of how health systems worldwide confuse “standard care” with equity. Sarah, a 34-year-old…